期刊文献+

心血管疾病中血管平滑肌细胞增殖与药物开发 被引量:4

Proliferation of vascular smooth muscle cells in cardiovascular diseases and drug research and development
下载PDF
导出
摘要 血管平滑肌细胞增殖在高血压、动脉粥样硬化、再狭窄等心血管疾病的发生、发展中起着重要的作用。本文对血管平滑肌细胞胞外调控因素、胞内信号传导、细胞周期的研究现状及基于此三方面的药物研发进行综述。 The proliferation of vascular smooth muscle cells plays an important role in the initiation and aggravation in cardiovascular diseases such as hypertension, arteriosclerosis, restenosis. This article reviewed the progress in the studies on extracellular influencing factors, intracellular signal transduction, cell cycle of vascular smooth muscle cells and the relative drug research and development.
出处 《中国临床药理学与治疗学》 CAS CSCD 2004年第8期845-850,共6页 Chinese Journal of Clinical Pharmacology and Therapeutics
关键词 血管平滑肌细胞 增殖 信号传导 细胞周 期:药物开发 vascular smooth muscle cell proliferation signal transduction cell cycle drug research and development
  • 相关文献

参考文献39

  • 1[1]Padmini K, Parask S, Hanjong J, Thomas M, Lincoln. Activation of mitogen-activated protein kinase pathway by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells[J]. J Biol Chem, 1999;274(48):34301 -9
  • 2[2]Tanima G, Jeffrey C, Chen, Darren E, Casteel, Tammy M, et al. cGMP-dependent protein kinase inhibits serum-response element-dependent transcription by inhibiting Rho activation and functions[J]. J Biol Chem, 2002;277(40):37382- 93
  • 3[3]Heiko E, Von DL, Victor JD. Therapeutic potential of nitric oxide synthase gene manipulation[J]. Circulation, 2001; 103:2760 - 5
  • 4[4]Jean FA, Francis B. Alteration in endothelial estrogen receptor expression: A potential key of vasculoprotection by estrogens[J]Circ Res, 2002;91:759 - 60
  • 5[5]Tomi S, Mikkola, Thomas B, Clarkson. Estrogen replacement therapy, atherosclerosis, and vascular function[J]. Cardiovasc Res, 2002;53:605- 19
  • 6[6]Raghvendra K, Dubey, Delbert G, Gillespie, Lefteris C, Zacharia, et al. Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms [ J ]. Biochem Biophys Res Commun, 2000;278:27- 33
  • 7[7]Takuya W, Rajbabu P, Shinji K, Takashi K, Claude R, Benedict. Lysophosphatidyl choline and reactive oxygen species mediate the synergistic effect of mildly oxidized LDL with serotonin on vascular smooth muscle cell proliferation [ J]. Circulation,2001;103:1440-5
  • 8[8]Rajbabu P, Claude B. Synergy between thrombin and serotonin in inducing vascular smooth muscle cell proliferation[J]. J Lab Clin Med, 1999; 134(6) :659 - 67
  • 9[9]Takuya W, Rajbabu P, Takashi K, Claude R. Benedict. Synergistic effect of urotensin Ⅱ with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells [ J ]. Circulation,2001;104:16- 8
  • 10[10]Michael T, Osinski, Karsten S. Inhibition of platelet-derived growth factor-induced mitogenesis by phosphodiesterase 3 inhibitors[J]. Biochem Pharmacol, 2000;60:381 - 7

同被引文献51

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部